Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Ameliorative effect of sesamin in cisplatin-induced nephrotoxicity in rats by suppressing inflammation, oxidative/nitrosative stress, and cellular damage

B. H. Ali, S. Al Salam, Y. Al Suleimani, M. Al Za'abi, M. Ashique, P. Manoj, M. Sudhadevi, M. Al Tobi, A. Nemmar

. 2020 ; 69 (1) : 61-72. [pub] 20191219

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20017814

Nephrotoxicity of cisplatin (CP) involves renal oxidative stress and inflammation, and sesamin (a major liganin in many plants) has strong antioxidant and antiinflammatory actions. Therefore, we investigated here the possible mitigative action of sesamin on CP nephrotoxicity in rats. Sesamin was given orally (5 mg/kg/day, 10 days), and on the 7th day, some of the treated rats were injected intraperitoneally with either saline or CP (5 mg/kg). On the 11th day, rats were sacrificed, and blood and urine samples and kidneys were collected for biochemical estimation of several traditional and novel indices of renal damage in plasma and urine, several oxidative and nitrosative indices in kidneys, and assessment of histopathological renal damage. CP significantly and adversely altered all the physiological, biochemical and histopathological indices of renal function measured. Kidneys of CP-treated rats had a moderate degree of necrosis. This was markedly lessened when CP was given simultaneously with sesamin. Sesamin treatment did not significantly alter the renal CP concentration. The results suggested that sesamin had ameliorated CP nephrotoxicity in rats by reversing the CP-induced oxidative stress and inflammation. Pending further pharmacological and toxicological studies sesamin may be considered a potentially useful nephroprotective agent.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20017814
003      
CZ-PrNML
005      
20210209141541.0
007      
ta
008      
201110s2020 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934142 $2 doi
035    __
$a (PubMed)31852200
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ali, B. H. $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
245    10
$a Ameliorative effect of sesamin in cisplatin-induced nephrotoxicity in rats by suppressing inflammation, oxidative/nitrosative stress, and cellular damage / $c B. H. Ali, S. Al Salam, Y. Al Suleimani, M. Al Za'abi, M. Ashique, P. Manoj, M. Sudhadevi, M. Al Tobi, A. Nemmar
504    __
$a Literatura
520    9_
$a Nephrotoxicity of cisplatin (CP) involves renal oxidative stress and inflammation, and sesamin (a major liganin in many plants) has strong antioxidant and antiinflammatory actions. Therefore, we investigated here the possible mitigative action of sesamin on CP nephrotoxicity in rats. Sesamin was given orally (5 mg/kg/day, 10 days), and on the 7th day, some of the treated rats were injected intraperitoneally with either saline or CP (5 mg/kg). On the 11th day, rats were sacrificed, and blood and urine samples and kidneys were collected for biochemical estimation of several traditional and novel indices of renal damage in plasma and urine, several oxidative and nitrosative indices in kidneys, and assessment of histopathological renal damage. CP significantly and adversely altered all the physiological, biochemical and histopathological indices of renal function measured. Kidneys of CP-treated rats had a moderate degree of necrosis. This was markedly lessened when CP was given simultaneously with sesamin. Sesamin treatment did not significantly alter the renal CP concentration. The results suggested that sesamin had ameliorated CP nephrotoxicity in rats by reversing the CP-induced oxidative stress and inflammation. Pending further pharmacological and toxicological studies sesamin may be considered a potentially useful nephroprotective agent.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x škodlivé účinky $7 D000970
650    _2
$a antioxidancia $x farmakologie $x terapeutické užití $7 D000975
650    _2
$a cisplatina $x škodlivé účinky $7 D002945
650    _2
$a dioxoly $x farmakologie $x terapeutické užití $7 D004149
650    _2
$a preklinické hodnocení léčiv $7 D004353
650    _2
$a ledviny $x účinky léků $x metabolismus $7 D007668
650    _2
$a nemoci ledvin $x chemicky indukované $x farmakoterapie $x metabolismus $7 D007674
650    _2
$a lignany $x farmakologie $x terapeutické užití $7 D017705
650    _2
$a mužské pohlaví $7 D008297
650    12
$a fytoterapie $7 D008517
650    _2
$a rostlinné extrakty $x terapeutické užití $7 D010936
650    _2
$a potkani Wistar $7 D017208
650    12
$a Sesamum $7 D031685
655    _2
$a časopisecké články $7 D016428
700    1_
$a Al Salam, S. $u Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
700    1_
$a Al Suleimani, Y. $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
700    1_
$a Al Za'abi, M.
700    1_
$a Ashique, M. $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
700    1_
$a Manoj, P. $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
700    1_
$a Sudhadevi, M. $u Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
700    1_
$a Al Tobi, M. $u Department of Biochemistry and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
700    1_
$a Nemmar, A. $u Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, č. 1 (2020), s. 61-72
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31852200 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20201110 $b ABA008
991    __
$a 20210205170101 $b ABA008
999    __
$a ok $b bmc $g 1619114 $s 1108006
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 69 $c 1 $d 61-72 $e 20191219 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20201110

Najít záznam

Citační ukazatele

Možnosti archivace